Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus

Cancer Gene Therapy

Volumn 12, Issue 4, 2005, Pages 389-396

  Armelini, Melissa Gava ^a   Muotri, Alysson Renato ^b   Marchetto, Maria Carolina Nasser ^a   De Lima Bessa, Keronninn Moreno ^a   Sarasin, Alain ^c   Menck, Carlos Frederico Martins ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

DNA repair; Recombinant adenovirus; Ultraviolet light; Xeroderma pigmentosum

Indexed keywords

ADENOVIRUS VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN; HELICASE; RNA POLYMERASE II; TRANSCRIPTION FACTOR IIH; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADENOVIRUS; ARTICLE; CELL CYCLE; COCKAYNE SYNDROME; CONTROLLED STUDY; DNA REPAIR; EXCISION REPAIR; FETUS; GENE MUTATION; GENE TARGETING; GENETIC COMPLEMENTATION; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNAL RIBOSOME ENTRY SITE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; RNA TRANSCRIPTION; SIMIAN VIRUS 40; SKIN FIBROBLAST; TRICHOTHIODYSTROPHY; VIRUS RECOMBINANT; WILD TYPE; XERODERMA PIGMENTOSUM;

ADENOVIRIDAE; BLOTTING, WESTERN; CELL LINE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; COCKAYNE SYNDROME; DNA; DNA HELICASES; DNA REPAIR; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, RADIATION; ECTODERMAL DYSPLASIA; FIBROBLASTS; FLOW CYTOMETRY; GENETIC COMPLEMENTATION TEST; HUMANS; KINETICS; MALE; MICROSCOPY, FLUORESCENCE; MODELS, GENETIC; MUTATION; PHENOTYPE; RECOMBINATION, GENETIC; RNA POLYMERASE II; SENSITIVITY AND SPECIFICITY; SKIN; TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS, TFII; ULTRAVIOLET RAYS; XERODERMA PIGMENTOSUM; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADENOVIRIDAE;

EID: 15744400744     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700797     Document Type: Article

References (52)

1. Tuteja N, Tuteja R. Unraveling DNA repair in human: molecular mechanisms and consequences of repair defect. Crit Rev Biochem Mol Biol. 2001;36:261-290.
2. Hanawalt PC. Transcription-coupled repair and human disease. Science. 1994;266:1957-1958.
3. Moriwaki S, Kraemer KH. Xeroderma pigmentosum - bridging a gap between clinic and laboratory. Photodermatol Photoimmunol Photomed. 2001;17:47-54.
4. Taylor EM, Lehmann AR. Conservation of eukaryotic DNA repair mechanisms. Int J Radiat Biol. 1998;74:277-286.
5. Berneburg M, Lowe JE, Nardo T, et al. UV damage causes uncontrolled DNA breakage in cells from patients with combined features of XP-D and Cockayne syndrome. EMBO J. 2000;19:1157-1166.
6. Costa RMA, Chiganças V, Galhardo RS, et al. The eukaryotic nucleotide excision repair pathway. Biochimie. 2003;85:1083-1099.
7. van Hoffen A, Balajee AS, van Zeeland AA, et al. Nucleotide excision repair and its interplay with transcription. Toxicology. 2003;193:79-90.
8. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis. 2002;17:463-469.
9. Schaeffer L, Moncollin V, Roy R, Staub A, et al. The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. EMBO J. 1994;13:2388-2392.
10. Roy R, Adamczewski JP, Seroz T, et al. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell. 1994;79:1093-1101.
11. Friedberg EC. Hot news: temperature-sensitive humans explain hereditary disease. Bioessays. 2001;23:671-673.
12. Coin F, Marinoni JC, Rodolfo C, et al. Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet. 1998;20:184-188.
13. Keriel A, Stary A, Sarasin A, et al. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell. 2002;109:125-135.
14. Cleaver JE, Thompson LH, Richardson AS, et al. A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Hum Mutat. 1999;14:9-22.
15. Kraemer KH, Herlyn M, Yuspa SH, et al. Reduced DNA repair in cultured melanocytes and nevus cells from a patient with xeroderma pigmentosum. Arch Dermatol. 1989;125:263-268.
16. Kraemer KH, Levy DD, Parris CN, et al. Xeroderma pigmentosum and related disorders: examining the linkage between defective DNA repair and cancer. J Invest Dermatol. 1994;103:S96-S101.
17. Stary A, Sarasin A. The genetics of the hereditary xeroderma pigmentosum syndrome. Biochimie. 2002;84:49-60.
18. de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis. 2000;21:453-460.
19. Bootsma D, Kraemer KH, Cleaver JE, et al. Nucleotide excision repair syndrome: xeroderma pigmentosum, Cockayne syndromes, and trichothiodystrophy. In: Vogelstein B, Kinzler KW, eds. The Genetics Basis of Human Cancer. New York, NY: McGraw-Hill; 1998: 245-274.
20. Nance MA, Berry SA. Cockayne syndrome: review of 140 cases. Am J Med Genet. 1992;42:68-84.
21. Itin PH, Pittelkow MR. Trichothiodystrophy: review of sulfur-deficient brittle hair syndromes and association with the ectodermal dysplasias. J Am Acad Dermatol. 1990;22:705-717.
22. Lehmann AR. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev. 2001;15:15-23.
23. Queille S, Drougard C, Sarasin A, et al. Effects of XPD mutations on ultraviolet-induced apoptosis in relation to skin cancer-proneness in repair-deficient syndromes. J Invest Dermatol. 2001;117:1162-1170.
24. Lehmann AR, Thompson AF, Harcourt SA, et al. Cockayne's syndrome: correlation of clinical features with cellular sensitivity of RNA synthesis to UV irradiation. J Med Genet. 1993;30:679-682.
25. Stefanini M, Lagomarsini P, Giliani S, et al. Genetic heterogeneity of the excision repair defect associated with trichothiodystrophy. Carcinogenesis. 1993;14:1101-1105.
26. Stefanini M, Vermeulen W, Weeda G, et al. A new nucleotide-excision- repair gene associated with the disorder trichothiodystrophy. Am J Hum Genet. 1993;4:817-821.
27. Vermeulen W, van Vuuren AJ, Chipoulet M, et al. Three unusual repair deficiencies associated with transcription factor BTF2(TFIIH): evidence for the existence of a transcription syndrome. Cold Spring Harb Symp Quant Biol. 1994;59:317-329.
28. de Boer J, de Witt J, van Steeg H, et al. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol Cell. 1998;1:981-990.
29. Carreau M, Quilliet X, Eveno E, et al. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients. Hum Gene Ther. 1995;6:1307-1315.
30. Quilliet X, Chevallier-Lagente O, Eveno E, et al. Long-term complementation of DNA repair deficient human primary fibroblasts by retroviral transduction of the XPD gene. Mutat Res. 1996;364:161-169.
31. Zeng L, Quilliet X, Chevallier-Lagente O, et al. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C. Gene Therapy. 1997;4:1077-1084.
32. Marchetto MCN, Muotri AR, Magalhães GS, et al. The EGFP recombinant adenovirus: an example of efficient gene delivery and expression in human cells. Virus Rev Res. 2001;6:23-33.
33. Benihoud K, Yeh P, Perricaudet M. Adenovirus vectors for gene delivery. Curr Opin Biotechnol. 1999;10:440-447.
34. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003;4:346-358.
35. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;17:415-419.
36. Williams DA, Baum C. Gene therapy - new challenges ahead. Science. 2003;302:400-401.
37. Muotri AR, Marchetto MCN, Zerbini LFC, et al. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group A and C cells by recombinant adenovirus-mediated gene transfer. Hum Gene Ther. 2002;13:1833-1844.
38. Itin PH, Sarasin A, Pittelkow MR. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol. 2001;44:891-920.
39. Coin F, Bergmann E, Tremeau-Bavard A, et al. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH. EMBO J. 1999;18:1357-1366.
40. Jackson RJ, Howell MT, Kaminski A. The novel mechanism of initiation of picornavirus RNA translation. Trends Biochem Sci. 1990;15:477-483.
41. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, ed. Methods in Molecular Biology. Clifton, NJ: The Humana Press Inc; 1991: 109-128.
42. Mittereder N, March KL, Trapnell BC. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol. 1996;70:7498-7509.
43. Sambrook J, Russel DW. Molecular Cloning: A Laboratory Manual. New York, NY: Cold Spring Harbour Laboratory Press; 2001.
44. In: Friedberg EC, Hanawalt PC, eds. Measurement of Unscheduled Synthesis by Autoradiography. New York, NY: Marcel Dekker, Inc; 1981: 227-287.
45. Berneburg M, Lehmann AR. Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Adv Genet. 2001;43:71-102.
46. Chen J, Larochelle S, Xiaoming L, et al. Xpd/Ercc2 regulates CAK activity and mitotic progression. Nature. 2003;424:228-232.
47. Muotri AR, Marchetto MCN, Suzuki MF, et al. Low amounts of the DNA repair XPA protein are sufficient to recover UV-resistance. Carcinogenesis. 2002;23:1039-1046.
48. Johnson RT, Squires S. The XP-D complementation group. Insigth into xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy. Mutat Res. 1992;273:97-118.
49. van Hoffen A, Kalle WH, Jong-Versteeg A, Lehmann AR, Zeeland AA, Mullenders LH. Cells from XP-D and XP-D-CS patients exhibit equally inefficient repair of UV-induced damage in transcribed genes but different capacity to recover UV-inhibited transcription. Nucleic Acids Res. 1999;27:2898-2904.
50. Broughton BC, Steingrimsdottir H, Webber C, et al. Mutations in the xeroderma pigmentosum group D DNA repair/transcription gene in patients with trichothiodystrophy. Nat Genet. 1994;7:189-194.
51. Taylor EM, Broughton BC, Botta E, et al. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci USA. 1997;94:8658-8663.
52. Berg RJ, de Vries A, van Steeg H, et al. Relative susceptibilities of XPA knockout mice and their heterozygous and wild-type littermates to UVB-induced skin cancer. Cancer Res. 1997;15:581-584.